UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported):  October 23, 2009



NUVILEX, INC.

(Exact name of registrant as specified in its charter)



Nevada

333-68008

62-1772151

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)


1971 Old Cuthbert Road

Cherry Hill, New Jersey


08034

(Address of Principal Executive Offices)

(Zip Code)


Registrant's telephone number, including area code (856) 354-0707


N/A

 (Former name or former address, if changed since last report.)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT


ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS


On October 23, 2009, The Registrant accepted the resignation of Robert J. Creeden as a member of the Registrant’s Board of Directors.  Mr. Creeden has submitted his resignation due to policies set by Partners Innovation Fund and its parent, Partners Healthcare regarding the holding of board seats for publicly traded companies.  Mr Creeden served as a member of the board of directors of Freedom2 and agreed to join the registrant’s board to provide some continuity during the transition period.

 


SIGNATURES


Pursuant to the  requirements of the Securities  Exchange Act of 1934, the registrant  has duly  caused  this  report  to be  signed  on its  behalf by the undersigned hereunto duly authorized.


                             

 NUVILEX, INC.

                                  

              (Registrant)


Date:  November 3, 2009

                                              

                                           

/s/ Martin Schmieg

                                            

Martin Schmieg

Chief Executive Officer


2